Akoya Biosciences’ PhenoCycler-Fusion platform used by QSBC

Akoya Biosciences announced that the newly established Queensland Spatial Biology Centre, QSBC, located in Brisbane, Australia, is using the PhenoCycler-Fusion spatial biology platform as the core technology to revolutionize the way cancer and other debilitating diseases are diagnosed and treated. The PhenoCycler-Fusion platform facilitates the understanding of the cellular compositions, neighborhoods, and functional states that are present in complex diseases, and that next generation therapeutics may be able to target. Bringing a new level of clarity to this complex biology will help explain why individual patients have varying degrees of success in terms of their response to treatment. “We are extremely excited to be an integral part of this important initiative,” said Brian McKelligon, Chief Executive Officer of Akoya Biosciences. “The QSBC has brought together a remarkable group of researchers, clinicians, pathologists, and computational biologists who are unrelenting in their commitment to leverage the enormous power of spatial biology. Their passion is inspiring and we look forward to supporting them with the most advanced spatial biology solutions.”